Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia

Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia

Show other versions (1)

"nIntroduction: The secondary genetic changes other than the PML-RARA fusion gene may contribute to the acute promyelocytic leukemogenesis. Chromosomal alterations and mutation of FLT3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (AML). However, th...

Full description

Bibliographic Details
Main Authors:	Marjan Yaghmaie, Hossein Mozdarani, Kamran Alimoghaddam, Ardeshir Ghavamzadeh, Seyed Hamiollah Ghaffari
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2010-07-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	Acute promyelocytic leukemia FLT3 tyrosine kinase Internal tandem duplication
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/18608.pdf&manuscript_id=18608

Similar Items

Evaluation of Cytogenetic Changes and FLT3 mutations in Patients with Acute Promyelocytic Leukemia
by: Marjan Yaghmaie, et al.
Published: (2010-09-01)

Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia
by: Song Y, et al.
Published: (2021-03-01)

Comparison of differences in blood laboratory results between acute promyelocytic leukemia and acute promyelocytic leukemia+FLT3-internal tandem duplication patients
by: Mehdi Mohammadi Kanesbi, et al.
Published: (2021-01-01)

FLT3 internal tandem duplication and FLT3-D835 mutation in 80 AML patients categorized into cytogenetic risk groups
by: Ewa Mały DEF, et al.
Published: (2010-10-01)

FMS-LIKE TYROSINE KINASE (FLT3) GENE ITD MUTATION IN ACUTE MYELOID LEUKEMIA
by: Rajko Kusec, et al.
Published: (2004-12-01)

The Impact of <i>Flt3</i> Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
by: Gledson L. Picharski, et al.
Published: (2019-09-01)

Molecular characteristics and chromatin texture features in acute promyelocytic leukemia
by: De Mello Mariana R B, et al.
Published: (2012-06-01)

Meta-Analysis of Gene Expression Profiles in Acute Promyelocytic Leukemia Reveals Involved Pathways
by: Mahdi Jalili, et al.
Published: (2016-12-01)

Characteristics and Prognosis of Adult Acute Myeloid Leukemia with Internal Tandem Duplication in the FLT3 Gene
by: Adhra Al-Mawali, et al.
Published: (2013-11-01)

Cytotoxic Effects Of Selective Inhibitor ‘Aurora Kinase B’ On Viability And Metabolic Features Of Human Promyelocytic Leukemia Cell Line
by: Samad Ghanizadeh Vesali, et al.
Published: (2013-09-01)

Cytotoxic Effects Of Selective Inhibitor ‘Aurora Kinase B’ On Viability And Metabolic Features Of Human Promyelocytic Leukemia Cell Line
by: Samad Ghanizadeh Vesali, et al.
Published: (2013-09-01)

Cytogenetics and FISH negative cryptic acute promyelocytic leukemia with CD56 expression
by: Jhansi Rani Arumugam, et al.
Published: (2021-01-01)

The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation–positive relapsed/refractory acute myeloid leukemia
by: Jessica K. Altman, et al.
Published: (2021-02-01)

An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment
by: Tiziana Grafone, et al.
Published: (2012-04-01)

Fetal and neonatal hematopoietic progenitors are functionally and transcriptionally resistant to Flt3-ITD mutations
by: Shaina N Porter, et al.
Published: (2016-11-01)

Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia
by: Xueya Zhang, et al.
Published: (2021-06-01)

ACUTE PROMYELOCYTE LEUKEMIA PRESENTING AS THROMBOTIC CEREBROVASCULAR ACCIDENT
by: E. Baybordi, et al.
Published: (1999-08-01)

ACUTE PROMYELOCYTE LEUKEMIA PRESENTING AS THROMBOTIC CEREBROVASCULAR ACCIDENT
by: E. Baybordi, et al.
Published: (1999-09-01)

Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
by: Sarah Cristina Bassi, et al.
Published: (2012-01-01)

Acute Promyelocytic Leukemia (APL) Relapsing into AML-M2 with Normal Cytogenetics. A report.
by: Ranjit Kumar Sahoo, et al.
Published: (2014-08-01)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-04-01)

FLT3 Gene Mutation in Acute Myeloid Leukemia: Correlation with Hematological, Immunophenotypic, and Cytogenetic Characteristics
by: Sunitha Shankaralingappa, et al.
Published: (2021-06-01)

TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
by: Nico Gagelmann, et al.
Published: (2021-03-01)

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.
by: Lionel Ades, et al.
Published: (2011-01-01)

TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.
by: Charicleia Kelaidi, et al.
Published: (2011-09-01)

<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
by: Andrew Y. Li, et al.
Published: (2021-03-01)

MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
by: Neil Osheroff, et al.
Published: (2011-01-01)

MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
by: Melanie Joannides, et al.
Published: (2011-10-01)

Expression of protein-tyrosine phosphatases in Acute Myeloid Leukemia cells: <it>FLT3 ITD sustains high levels of DUSP6 expression</it>
by: Arora Deepika, et al.
Published: (2012-07-01)

The biology and targeting of FLT3 in pediatric leukemia
by: Colleen eAnnesley, et al.
Published: (2014-09-01)

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance
by: Dilana Staudt, et al.
Published: (2018-10-01)

Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
by: Sebastian Scholl, et al.
Published: (2020-11-01)

MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
by: Francesco Lococo, et al.
Published: (2013-06-01)

FLT3 inhibitors in acute myeloid leukemia
by: Mei Wu, et al.
Published: (2018-12-01)

High WT1 expression is an early predictor for relapse in patients with acute promyelocytic leukemia in first remission with negative PML-RARa after anthracycline-based chemotherapy: a single-center cohort study
by: Jae-Ho Yoon, et al.
Published: (2017-01-01)

Seasonality in acute promyelocytic leukemia: Fact or myth?
by: Amer Shareef Mohammed, et al.
Published: (2020-01-01)

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
by: Juanjuan Zhao, et al.
Published: (2019-09-01)

Mutations of FLT3 receptor affect its surface glycosylation, intracellular localization, and downstream signaling
by: Shinichiro Takahashi
Published: (2020-01-01)

Clinical use of FLT3 inhibitors in acute myeloid leukemia
by: Sutamtewagul G, et al.
Published: (2018-10-01)

Acute promyelocytic leukemia. State of the art
by: Leonardo Mejía-Buriticá, et al.
Published: (2021-01-01)